Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2
- 1 May 2001
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 37 (7) , 892-902
- https://doi.org/10.1016/s0959-8049(01)00063-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigensLife Sciences, 1997
- In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific AntigenJNCI Journal of the National Cancer Institute, 1997
- Biological indices predictive of survival in 519 Italian terminally Ill cancer patientsJournal of Pain and Symptom Management, 1997
- Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicabilityJournal of Immunological Methods, 1996
- Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?Immunology Today, 1995
- Autocrine Feedback Death and the Regulation of Mature T Lymphocyte Antigen ResponsesInternational Reviews of Immunology, 1995
- Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignanciesThe Lancet, 1990
- Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.Journal of Clinical Investigation, 1990
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989
- Hematopoietic growth factors.Journal of Clinical Investigation, 1987